United States · FDA National Drug Code directory
Phenazopyridine Hydrochloride
A source-listed medicine record.
Factual source checks only. This page is not a clinically reviewed monograph. Historical or discontinued records may be included; listing does not confirm approval, current availability or pharmacy stock.
Medicine identity
- Source reference
- 50090-6952_ba94af0c-ff74-484c-9a83-21e4dacb15a7
- Product NDC
- 50090-6952
- Form
- TABLET
- Composition / generic term
- Phenazopyridine Hydrochloride
- Labeler
- A-S Medication Solutions
- Marketing category
- UNAPPROVED DRUG OTHER
- Marketing start / end (source format)
- 20231019
- Source listing expiry
- 20261231
Source-listed ingredients
- PHENAZOPYRIDINE HYDROCHLORIDE — 200 mg/1
These values do not establish equivalence or a dose recommendation.
Packages
- 10 TABLET in 1 BOTTLE (50090-6952-0) · 50090-6952-0
- 15 TABLET in 1 BOTTLE (50090-6952-1) · 50090-6952-1
- 6 TABLET in 1 BOTTLE (50090-6952-4) · 50090-6952-4
- 12 TABLET in 1 BOTTLE (50090-6952-6) · 50090-6952-6
- 9 TABLET in 1 BOTTLE (50090-6952-7) · 50090-6952-7
Source and coverage
Open FDA National Drug Code directory →
Snapshot retrieved: 2026-09-17. This is the acquisition date, not a medical review date.
Clinical information, images and comparisons appear only when separately reviewed for this record. Coverage may be incomplete. Ask a pharmacist or clinician about your treatment.
Browse United States records →